Veterinary Medicines

VITAMIN AD3E FORTE, süstelahus

Authorised
  • Retinol palmitate
  • Colecalciferol
  • ALPHATOCOPHEROL ACETATE
Download as PDF

Product identification

Medicine name:
VITAMIN AD3E FORTE, süstelahus
Active substance:
  • Retinol palmitate
  • Colecalciferol
  • ALPHATOCOPHEROL ACETATE
Target species:
  • Cattle
  • Horse
  • Sheep
  • Goat
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Retinol palmitate
    500000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Colecalciferol
    75000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • ALPHATOCOPHEROL ACETATE
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11JA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alfasan International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan International B.V.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1474
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 28/01/2022
Download